SCHEMBL10719652

SCHEMBL10719652

FC(F)(F)c1cnc2nc[nH]c2c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.41
METAP2 P50579 1/20 0.41
KDM4E B2RXH2 2/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TEK Q02763 1/20 0.37
TRPA1 O75762 2/20 0.37
PARP1 P09874 1/20 0.37
ALDH1A1 P00352 2/20 0.36
KCNH2 Q12809 1/20 0.35
HTT P42858 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MAPT P10636 1/20 0.35
S1PR1 P21453 1/20 0.34
CTSS P25774 1/20 0.34
CTSK P43235 1/20 0.34
PIK3CA P42336 1/20 0.33
MTOR P42345 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12689500 0.81 ALDH1A1 (0.36) AURKAKDM4ETEKALDH1A1KCNH2
SCHEMBL30176714 0.76 CTSS (0.49) TEKPARP1ALDH1A1CTSSCTSK
SCHEMBL21906548 0.74 ALDH1A1 (0.39) METAP2KDM4EALDH1A1MAPTPIK3CA
SCHEMBL29658121 0.73 ALDH1A1 (0.33) METAP2KDM4EPARP1ALDH1A1PIK3CA
SCHEMBL3229989 0.71 KDM4E (0.50) AURKAKDM4EALDH1A1HTTHSD17B10
SCHEMBL11773659 0.70 HSD17B10 (0.70) AURKAMETAP2KDM4ERAB9ASMN1; SMN2
SCHEMBL324998 0.69 ALDH1A1 (0.39) KDM4EALDH1A1MAPTPIK3CA
SCHEMBL620396 0.69 SMN1; SMN2 (0.48) AURKAMETAP2KDM4ESMN1; SMN2ALDH1A1
SCHEMBL2190488 0.69 ALDH1A1 (0.48) KDM4EPARP1ALDH1A1HTTMAPT
SCHEMBL8367003 0.69 KDM4E (0.39) AURKAMETAP2KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166156-B Tyrosine kinase inhibitors, compositions and methods 贝达药业股份有限公司 2024-02-27 CN claimed
JP-62195379-A None JP disclosed
US-12144349-B2 Pesticidal mixtures comprising a mesoionic compound BASF SE (DE) 2024-11-19 US disclosed
CN-113166156-B Tyrosine kinase inhibitors, compositions and methods 贝达药业股份有限公司 2024-02-27 CN disclosed
CN-117355519-A Novel substituted pyridines as fungicides 巴斯夫欧洲公司 2024-01-05 CN disclosed
CN-110526911-B Pesticidally active heterocyclic derivatives with sulfur-containing substituents 先正达参股股份有限公司 2022-09-13 CN disclosed
JP-S62195379-A 6-TRIFLUOROMETHYLIMIDAZO(4,5-B)PYRIDINE COMPOUND AND NOXIOUS-LIFE CONTROLLING AGENT CONTAINING SAME ISHIHARA SANGYO KAISHA LTD 1987-08-28 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12144349-B2 Pesticidal mixtures comprising a mesoionic compound ACHE, DDT, MTX2 AURKA 2558/4885METAP2 5/4885KDM4E 4556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.